The CECOG Targeted Fellowship is a cooperation with the Medical University Vienna and the Comprehensive Cancer Center Vienna and is made possible by education grants from Pfizer Oncology, MERCK and Bristol-Myers Squibb.
- Therapy with targeted agents (e.g. antibodies, tyrosine kinase inhibitors) is established in several cancer types
- Drug access to targeted agents is severely limited in some countries in Central and Eastern Europe (e.g. Romania, Bulgaria), thus leading to (1) limited treatment options in some cancer indications and (2) lack of training experience with novel therapeutics for young oncologists
- To enable young oncologists from central eastern Europe to gain experience with cancer treatment using biological agents
- To develop new trial initiatives with targeted agents and young oncologists from Eastern and Central Europe in responsible positions
- This initiative will facilitate equality in cancer care across Europe
- 4 – 6 weeks stay at Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna
- Observership at in- and outpatient clinics
- Attendance of tumor boards, lectures and journal clubs
- Preparation of a trial proposal (study synopsis) during the stay
- Training in personalized medicine
- Participation in tumor boards
- Be oncologists or oncologists in training with at least 6 months of clinical experience in internal medicine or medical, radiation or surgical oncology
- Be under the age of 40
- Be proficient in English or German
If you are interested to take part in the program, please send your CV and indicate the desired date and duration of your stay.
The Program is not available in the month of June, July and August and over the Christmas period.
Please note that we need about 8-10 weeks preparation time to get permission from the International Department of the Medical University.
Travel and accommodation will be provided.